Photo credit: Paul Odongo/MSF
Open letter to Eli Lilly on barriers to accessing diabetes medicines
MSF sent this open letter to the CEO of the pharmaceutical corporation Eli Lilly highlighting our concerns about their approach to the supply and pricing of their diabetes medicines, and urging action for greater access to these medicines for people with diabetes.